Trial intelligence / Profile preview

Trazodone for sleep and mood symptoms after methamphetamine detoxification

ChiCTR-IPR-14005681Phase 4Recruiting

Sponsor
Ningbo Addiction Research and Treatment Center
Start
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of trazodone in methamphetamine use disorder (MUD) (2 arms), sponsored by Ningbo Addiction Research and Treatment Center. Primary endpoints: Pittsburgh Sleep Quality Index, Hamilton Anxiety Scale and 3 more. Started Jan 2015; status: recruiting.

02

Drugs

trazodone
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on ChiCTR-IPR-14005681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-14005681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call